[1] 宋扬, 赵丽艳, 陈勇, 等. TGFβ1对胶质瘤U87细胞上皮-间质转化的诱导作用[J]. 吉林大学学报:医学版, 2016, 42(6):1087-1091. [2] Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas[J]. Cancer Lett, 2013, 331(2):131-138. [3] Lee JK, Joo KM, Lee J, et al. Targeting the epithelial to mesenchymal transition in glioblastoma:the emerging role of MET signaling[J]. Onco Targets Ther, 2014, 7:1933-1944. [4] Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance[J]. Cancer Sci, 2010, 101(2):293-299. [5] Marcucci F, Stassi G, De Maria R. Epithelial-mesenchymal transition:a new target in anticancer drug discovery[J]. Nat Rev Drug Discov, 2016, 15(5):311-325. [6] Han G, Xia J, Gao J, et al. Anti-tumor effects and cellular mechanisms of resveratrol[J]. Drug Discov Ther, 2015, 9(1):1-12. [7] Iser IC, Pereira MB, Lenz G, et al. The epithelial-to-mesenchymal transition-like process in glioblastoma:An updated systematic review and in silico investigation[J]. Med Res Rev, 2017, 37(2):271-313. [8] 宋扬, 赵丽艳, 李蕴潜,等. 胶质瘤细胞上皮-间质转化及靶向抑制策略的研究进展[J]. 吉林大学学报:医学版, 2017, 43(5):1064-1066. [9] Cervantes-Arias A, Pang LY, Argyle DJ. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype[J]. Vet Comp Oncol, 2013, 11(3):169-184. [10] Gheldof A, Berx G. Cadherins and epithelial-to-mesenchymal transition[J]. Prog Mol Biol Transl Sci, 2013, 116:317-336. [11] Kahlert UD, Maciaczyk D, Doostkam S, et al. Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition[J]. Cancer Lett, 2012, 325(1):42-53. [12] Brabletz T. To differentiate or not-routes towards metastasis[J]. Nat Rev Cancer, 2012, 12(6):425-436. [13] Davis FM, Stewart TA, Thompson EW, et al. Targeting EMT in cancer:opportunities for pharmacological intervention[J]. Trends Pharmacol Sci, 2014, 35(9):479-488. [14] Li J, Chong T, Wang Z, et al. A novel anticancer effect of resveratrol:Reversal of epithelial mesenchymal transition in prostate cancer cells[J]. Mol Med Rep, 2014, 10(4):1717-1724. [15] Wang H, Zhang H, Tang L, et al. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis[J]. Toxicology, 2013, 303:139-146. [16] Li W, Ma J, Ma Q, et al. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway[J]. Curr Med Chem, 2013, 20(33):4185-4194. [17] Tania M, Khan MA, Fu J. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer[J]. Tumor Biol, 2014, 35(8):7335-7342. [18] Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells[J]. Biochim Biophys Acta, 2005, 1755(1):37-69. [19] Bai Y, Yang H, Zhang G, et al. Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells[J]. Mol Med Rep, 2017, 15(2):885-889. [20] Suh J, Kim DH, Surh YJ. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk[J]. Arch Biochem Biophys, 2018, 643:62-71. [21] 鲁艳杰,刘绍晨,胡亚涛,等.TGF-β_1对人绒毛膜癌细胞上皮间质转化及其迁移能力的促进作用研究[J].解放军医学杂志,2016,41(2):114-118. [22] Liu X, Fan D. The epithelial-mesenchymal transition and cancer stem cells:functional and mechanistic links[J]. Curr Pharm Des, 2015, 21(10):1279-1291. [23] Sato R, Semba T, Saya H, et al. Concise Review:Stem cells and epithelial-mesenchymal transition in cancer:Biological implications and therapeutic targets[J]. Stem Cells, 2016, 34(8):1997-2007. |